People: iCAD Inc (ICAD.PH)

Summary

Name	Age	Since	Current Position
Lawrence Howard	60	2007	Chairman of the Board
Kenneth Ferry	59	2006	President, Chief Executive Officer, Director
Kevin Burns	42	2011	Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary
Stacey Stevens	45	2006	Senior Vice President - Marketing and Strategy
Jonathan Go	50	2006	Senior Vice President - Research and Development
Rachel Brem	54	2004	Independent Director
Anthony Ecock	51	2008	Independent Director
Michael Klein	59	2010	Independent Director
Steven Rappaport	64	2006	Independent Director
Somu Subramaniam	58	2010	Independent Director
Elliot Sussman	61	2002	Independent Director

» Insider Trading

Biographies

Name	Description
Lawrence Howard	Dr. Lawrence Howard is Chairman of the Board of iCAD Inc., since November 16, 2007. He has been a director of the Company since November 2006. Dr. Howard has been, since March 1997, a general partner of Hudson Ventures, L.P. (formerly known as Hudson Partners, L.P.), a limited partnership that is the general partner of Hudson Venture Partners, L.P. (“HVP”), a limited partnership that is qualified as a small business investment company. Since March 1997, Dr. Howard has also been a managing member of Hudson Management Associates LLC, a limited liability company that provides management services to HVP. Since November 2000, Dr. Howard has been a General Partner of Hudson Venture Partners II, and a limited partner of Hudson Venture II, L.P. He was a founder and has been since November 1987, and continues to be, a director of Presstek, Inc. (“Presstek”), a public company which has developed proprietary imaging and consumables technologies for the printing and graphic arts industries, and served in various officer positions at Presstek from October 1987 to June 1993, lastly as its Chief Executive Officer.
Kenneth Ferry	Mr. Kenneth Ferry is President, Chief Executive Officer, Director of iCAD Inc., since May 15, 2006. He has over 25 years of experience in the healthcare technology field, with more than 10 years’ experience in senior management positions. Prior to joining the Company, from October 2003 to May 2006, Mr. Ferry was Senior Vice President and General Manager for the Global Patient Monitoring business for Philips Medical Systems. In this role he was responsible for Research & Development, Marketing, Business Development, Supply Chain and Manufacturing, Quality and Regulatory, Finance and Human Resources. From September 2001 to October 2003, Mr. Ferry served as a Senior Vice President in the North America Field Organization of Philips Medical Systems. From 1983 to 2001, Mr. Ferry served in a number of management positions with Hewlett Packard Company, a global provider of products, technologies, software solutions and services to individual consumers and businesses and Agilent Technologies, Inc., a provider of core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries.
Kevin Burns	Mr. Kevin C. Burns is Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary of iCAD Inc., since April 2011. Mr. Burns has approximately twenty years of professional experience in finance primarily in the technology industry. Most recently, Mr. Burns served as senior vice president and chief financial officer at AMICAS, Inc., a publicly traded image and information management solutions company. During his tenure at AMICAS, from November 2004 to May 2010, Mr. Burns led revenue and profit growth and effected a sale of the company. Prior to joining AMICAS, Mr. Burns was responsible for corporate planning at NMS Communications, a public telecom equipment company in the wireless applications and infrastructure market, from November 2003 to November 2004. Previously, Mr. Burns was the director of corporate development at Demantra, Inc. and has also held senior management positions in finance, accounting and corporate development at MAPICS, Inc. and Marcam Corporation, both public software companies. Mr. Burns earned both a Bachelor of Science degree in Finance and an MBA degree from Babson College.
Stacey Stevens	Ms. Stacey M. Stevens is Senior Vice President - Marketing and Strategy of iCAD Inc., since June 2006. Prior to joining iCAD, Ms. Stevens experience included a variety of sales, business development, and marketing management positions with Philips Medical Systems, Agilent Technologies, Inc. and Hewlett Packard’s Healthcare Solutions Group (which was acquired in 2001 by Philips Medical Systems). From February 2005 until joining the Company she was Vice President, Marketing Planning at Philips Medical Systems, where she was responsible for the leadership of all global marketing planning functions for Philips’ Healthcare Business. From 2003 to January 2005, she was Vice President of Marketing for the Cardiac and Monitoring Systems Business Unit of Philips where she was responsible for all marketing and certain direct sales activities for the America’s Field Operation. Prior to that, Ms. Stevens held several key marketing management positions in the Ultrasound Business Unit of Hewlett-Packard/Agilent and Philips Medical Systems. Ms. Stevens earned a Bachelor of Arts Degree in Political Science from the University of New Hampshire, and an MBA from Boston University’s Graduate School of Management.
Jonathan Go	Mr. Jonathan Go is Senior Vice President - Research and Development of iCAD Inc., since October 2006. From February 1998 to May 2006, Mr. Go served as Vice President of Engineering at Merge eMed Inc., a provider of Radiology Information System and Picture Archiving and Communication Systems solutions for imaging centers, specialty practices and hospitals. At Merge eMed, Mr. Go was responsible for software development, product management, testing, system integration and technical support for all of eMed’s products. From July 1986 to January 1998, Mr. Go held various development roles at Cedara Software Corp. in Toronto culminating as Director of Engineering. Cedara Software is focused on the development of custom engineered software applications and development tools for medical imaging manufacturers. At Cedara Mr. Go built the workstation program, developing multiple specialty workstations that have been adopted by a number of partners. Mr. Go earned a Bachelor of Science in Electrical Engineering from the University of Michigan and a Masters of Science in Electrical Engineering and Biomedical Engineering from the University of Michigan.
Rachel Brem	Dr. Rachel Brem, M.D., is Independent Director of iCAD Inc. She is currently the Professor and Vice Chairman in the Department of Radiology at The George Washington University Medical Center and Associate Director of the George Washington Cancer Institute. Dr. Brem has been at the George Washington University since 2000. From 1991 to 1999 Dr. Brem was at the John Hopkins Medical Institution where she introduced image guided minimally invasive surgery and previously was the Director of Breast Imaging. Dr. Brem is a nationally and internationally recognized experienced in new technologies for the improved diagnosis of breast cancer and has published over 80 manuscripts.
Anthony Ecock	Mr. Anthony F. Ecock is Independent Director of iCAD Inc. He is a General Partner with the private equity investment firm of Welsh, Carson, Anderson & Stowe (“WCAS”), which he joined in 2007. He has 25 years of experience in the healthcare field with 8 years in senior management positions at healthcare technology companies. At WCAS, Mr. Ecock leads the Resources Group, a team responsible for helping its 30 portfolio companies identify and implement initiatives to increase growth, earnings and cash flow. Before joining WCAS, he served as Vice President and General Manager of GE Healthcare’s Enterprise Sales organization from 2003 to 2007. From 1999 to 2003, he served as Senior Vice President and Global General Manager of Hewlett Packard’s, then Agilent’s and finally Philips’ Patient Monitoring divisions. Mr. Ecock spent his early career at the consulting firm of Bain & Company, where he was a Partner in the healthcare and technology practices and Program Director for Consultant Training.
Michael Klein	Mr. Michael Klein is Independent Director of iCAD Inc. He is currently the Chief Executive Officer at US HIFU, previously he was President and CEO of Xoft, Inc, a position he held since 2005 until the sale of Xoft to iCAD, Inc. in December 2010. Mr. Klein led the development, approval and commercialization of Xoft’s non-radioactive x-ray technology for radiation therapy. The Xoft platform offering is used to treat breast, vaginal and skin cancers. Prior to joining Xoft, from 2000 to 2004, Mr. Klein served as Chairman, President and CEO of R2 Technology, Inc., a breast and lung cancer computer aided detection company. From 1997 to 2000 he served as General Manager of Varian Medical Systems’ Oncology Group Mr. Klein has also served on the Board of Sanarus Medical, a breast biopsy and cryo-ablation company focused on the treatment of fibro adenomas. He received his MBA degree from the New York Institute of Technology and completed his post-graduate Executive Education Studies at Harvard University and Babson College. In 2008, Mr. Klein received the R&D Magazine Top 100 Award on behalf of Xoft, where honors were awarded for the 100 most technologically new products of 2008. A similar award was received in 2008 from Frost & Sullivan.
Steven Rappaport	Mr. Steven N. Rappaport is Independent Director of iCAD Inc. He has been a partner of RZ Capital, LLC since July 2002, a private investment firm that also provides administrative services for a limited number of clients. From March 1995 to July 2002, Mr. Rappaport was Director, President and Principal of Loanet, Inc., an online real-time accounting service used by brokers and institutions to support domestic and international securities borrowing and lending activities. Loanet, Inc. was acquired by SunGard Data Systems in May 2001. From March 1992 to December 1994, Mr. Rappaport was Executive Vice President of Metallurg, Inc. (“Metallurg”), a producer and seller of high quality specialty metals and alloys, and President of Metallurg’s subsidiary, Shieldalloy Corporation. He served as Director of Metallurg from 1985 to 1998. From March 1987 to March 1992, Mr. Rappaport was Director, Executive Vice President and Secretary of Telerate, Inc. (“Telerate”), an electronic distributor of financial information. Telerate was acquired by Dow Jones over a number of years commencing in 1985 and culminating in January 1990, when it became a wholly-owned subsidiary. Mr. Rappaport practiced corporate and tax law at the New York law firm of Hartman & Craven from August 1974 to March 1987. He became a partner in the firm in 1979. Mr. Rappaport is currently serving as an independent director of Presstek and a number of open and closed end American Stock Exchange funds of which Credit Suisse serves as the investment adviser and a number of closed end mutual funds of which Aberdeen Investment Trust serves as the adviser. In addition, Mr. Rappaport serves as a director of several privately owned businesses and a few not for profit organizations.
Somu Subramaniam	Mr. Somu Subramaniam is IIndependent Director of iCAD Inc. He is currently a Managing Partner and co-founder of New Science Ventures, a New York-based venture capital firm that invests in both early and late stage companies, using novel scientific approaches to address unmet needs and create order of magnitude improvements in performance. Mr. Subramaniam serves on several Boards of companies managed in New Science Venture’s portfolio, including Achronix Semiconductor Corporation, RF Arrays, Inc., Lightwire, Inc., Silicon Storage Technology, Inc., MagSil Corporation, Trellis BioScience, Inc., and BioScale, Inc. Prior to starting New Science Ventures in 2004, Mr. Subramaniam was a Director at McKinsey & Co. and at various times led their Strategy Practice, Technology Practice and Healthcare Practice. While at McKinsey, he advised multinational companies in the pharmaceuticals, medical devices, biotechnology, photonics, software and semiconductor industries. He was also a member of McKinsey’s Investment Committee. Mr. Subramaniam received his undergraduate degree (B.Tech) from the Indian Institute of Technology and his M.B.A. from Harvard Business School.
Elliot Sussman	Dr. Elliot J. Sussman, M.D., is Independent Director of iCAD Inc. He is currently the Chairman of The Villages Health and Professor of Medicine at the University of South Florida College of Medicine. From 1993 to 2010, Dr. Sussman served as President and Chief Executive Officer of Lehigh Valley Health Network. Dr. Sussman served as a Fellow in General Medicine and a Robert Wood Johnson Clinical Scholar at the University of Pennsylvania, and trained as a resident at the Hospital of the University of Pennsylvania. Dr. Sussman is a director and the Chairperson of the compensation committee of the Board of Directors of Universal Health Realty Income Trust, a public company involved in real estate investment trust primarily engaged in investing in healthcare and human service-related facilities.

Basic Compensation

Name	Fiscal Year Total
Lawrence Howard	--
Kenneth Ferry	1,186,250
Kevin Burns	--
Stacey Stevens	459,285
Jonathan Go	441,134
Rachel Brem	--
Anthony Ecock	--
Michael Klein	--
Steven Rappaport	--
Somu Subramaniam	--
Elliot Sussman	--

As Of 30 Dec 2011

Options Compensation

Name	Options	Value
Lawrence Howard	0	0
Kenneth Ferry	50,000	137,574
Kevin Burns	0	0
Stacey Stevens	15,000	32,851
Jonathan Go	0	0
Rachel Brem	0	0
Anthony Ecock	0	0
Michael Klein	0	0
Steven Rappaport	0	0
Somu Subramaniam	0	0
Elliot Sussman	0	0

Insider Trading

Name	Shares Traded	Price
BURNS KEVIN C	500	$5.19
BURNS KEVIN C	100	$5.15
BURNS KEVIN C	2,300	$5.19
STEVENS STACEY M	1,585	$5.49
STEVENS STACEY M	25,000	$0.00
FERRY KENNETH M	60,000	$0.00
BURNS KEVIN C	30,000	$0.00
GO JONATHAN	25,000	$0.00
BURNS KEVIN C	7,500	$2.10
BURNS KEVIN C	7,500	$2.05
BURNS KEVIN C	3,939	$2.89
BURNS KEVIN C	25,000	$2.90
HOWARD LAWRENCE	140,000	$0.00
HOWARD LAWRENCE	46,000	$0.00
HOWARD LAWRENCE	46,000	$0.00
SUSSMAN ELLIOT J	6,801	$0.52
SUSSMAN ELLIOT J	9,500	$0.52
SUSSMAN ELLIOT J	5,500	$0.50
SUSSMAN ELLIOT J	6,000	$0.50
SUSSMAN ELLIOT J	7,500	$0.49
SUSSMAN ELLIOT J	7,500	$0.50
SUSSMAN ELLIOT J	7,500	$0.50
SUSSMAN ELLIOT J	1,400	$0.51
SUSSMAN ELLIOT J	3,600	$0.50
SUSSMAN ELLIOT J	7,500	$0.50

» Full list on Insider Trading

People: iCAD Inc (ICAD.PH)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: